[Federal Register Volume 87, Number 224 (Tuesday, November 22, 2022)]
[Notices]
[Pages 71344-71345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25392]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Advisory Board and NCI Board of Scientific Advisors.
The meeting will be held as a virtual meeting and is open to the
public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov/).
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
section 552b(c)(6), Title 5 U.S.C., as amended. The intramural programs
and projects and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the
intramural programs and projects, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: December 5, 2022.
Closed: 11:00 a.m. to 1:05 p.m.
Agenda: Review of intramural program site visit outcomes and the
discussion of confidential personnel issues.
Open: 1:15 p.m. to 4:30 p.m.
Agenda: NCAB Subcommittee Meetings.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: December 6, 2022.
Open: 1:00 p.m. to 5:30 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors, NCI Director's report and
presentations, NCI Board of Scientific Advisors Concepts Review.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: December 7, 2022.
Open: 1:00 p.m. to 5:00 p.m.
[[Page 71345]]
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors, NCI Board of Scientific Advisors
Concepts Review and presentations.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Paulette S. Gray, Ph.D., Director Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Room 7W444, Bethesda, MD 20892, 240-276-6340, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: NCAB: https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm, BSA: https://deainfo.nci.nih.gov/advisory/bsa/bsameetings.htm, where an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: November 17, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-25392 Filed 11-21-22; 8:45 am]
BILLING CODE 4140-01-P